BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Righi E, Gallo T, Azzini AM, Mazzaferri F, Cordioli M, Merighi M, Tacconelli E. A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency. Infect Dis Ther 2021;10:637-61. [PMID: 33687662 DOI: 10.1007/s40121-021-00404-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wagner A, Jasinska J, Tomosel E, Zielinski CC, Wiedermann U. Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments. Vaccine 2021:S0264-410X(21)01401-8. [PMID: 34785100 DOI: 10.1016/j.vaccine.2021.10.068] [Reference Citation Analysis]
2 Shafiekhani M, Dehghani A, Shahisavandi M, Nabavizadeh SA, Kabiri M, Hassani AH, Haghpanah A. Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review. Ther Adv Urol 2021;13:17562872211046794. [PMID: 34603508 DOI: 10.1177/17562872211046794] [Reference Citation Analysis]
3 Allegra A, Tonacci A, Musolino C, Pioggia G, Gangemi S. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. Front Immunol 2021;12:738915. [PMID: 34759921 DOI: 10.3389/fimmu.2021.738915] [Reference Citation Analysis]
4 Froneman C, Kelleher P, José RJ. Pneumococcal Vaccination in Immunocompromised Hosts: An Update. Vaccines (Basel) 2021;9:536. [PMID: 34063785 DOI: 10.3390/vaccines9060536] [Reference Citation Analysis]